Meta ‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
In conclusion, the currently available evidence shows that WBRT plus TMZ increases the overall response rate in patients with brain metastases of NSCLC compared with WBRT alone.
The currently available evidence shows that whole‐brain radiotherapy (WBRT) plus temozolomide increases the overall response rate in patients with brain metastases of non‐small‐cell lung cancer compared with WBRT alone.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Yong Xin, WenWen Guo, Chun Sheng Yang, Qian Huang, Pei Zhang, Long Zhen Zhang, Guan Jiang Tags: Original Research Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Gastroenterology | Headache | Hematology | Lung Cancer | Migraine | Neurology | Non-Small Cell Lung Cancer | Temodar